• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估向英国黄卡计划报告药物不良反应的公众报告方法的可用性。

Assessing the usability of methods of public reporting of adverse drug reactions to the UK Yellow Card Scheme.

机构信息

Division of Social Pharmacy, University of Nottingham, Nottingham, UK.

出版信息

Health Expect. 2012 Dec;15(4):433-40. doi: 10.1111/j.1369-7625.2011.00686.x. Epub 2011 Apr 27.

DOI:10.1111/j.1369-7625.2011.00686.x
PMID:21521431
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5060635/
Abstract

OBJECTIVES

The aim of this study, which was part of the first independent evaluation of patient reporting of adverse drug reactions (ADRs) to the Yellow Card Scheme, was to observe the three reporting systems (paper, internet and telephone) 'in use' in a simulated setting to identify aspects which facilitated or hindered reporting.

METHODS

Forty adult participants were recruited from the general public using posters in pharmacies and a press article, and from a pool of volunteer simulated patients maintained by University of Nottingham medical and pharmacy schools. The participants, in seven groups that met at different times, were asked to 'think aloud,' as they were individually observed completing the reporting process for the paper and internet system, highlighting their thoughts and any issues encountered. They were asked to talk about their experience of reporting immediately after they had reported by telephone. Data from the field notes were analysed thematically and supplemented with relevant information from digital audio recordings.

CONCLUSIONS

Usability testing using the 'think aloud' approach worked well and identified areas of the Yellow Card reporting system which could be improved. Whilst the three methods of reporting available to the public are all reasonably 'fit for purpose', there were many suggestions identified for improving ease of completion and data quality, especially for the internet system. When systems for reporting of ADRs are designed, they should be tested by potential users before they are launched, so that potential problems are identified in advance.

摘要

目的

本研究是对不良药物反应(ADR)向黄卡计划报告的首次独立评估的一部分,旨在观察(模拟环境下的)三种报告系统(纸质、网络和电话)的“实际使用”情况,以确定促进或阻碍报告的各个方面。

方法

通过在药店张贴海报和一篇新闻文章,以及从诺丁汉大学医学和药学院维护的志愿者模拟患者库中招募了 40 名成年参与者。这些参与者被分为七个小组,在不同的时间会面,他们被要求在单独观察他们完成纸质和网络系统的报告过程中“大声思考”,强调他们的想法和遇到的任何问题。他们被要求在通过电话报告后立即谈论他们的报告经验。从现场记录中分析数据,并从数字音频记录中补充相关信息。

结论

使用“大声思考”方法进行的可用性测试效果很好,并确定了黄卡报告系统可以改进的领域。虽然公众可以使用的三种报告方法都基本“适用”,但仍有许多建议可以提高完成的便利性和数据质量,尤其是网络系统。在设计 ADR 报告系统时,应在推出前由潜在用户进行测试,以便提前发现潜在问题。

相似文献

1
Assessing the usability of methods of public reporting of adverse drug reactions to the UK Yellow Card Scheme.评估向英国黄卡计划报告药物不良反应的公众报告方法的可用性。
Health Expect. 2012 Dec;15(4):433-40. doi: 10.1111/j.1369-7625.2011.00686.x. Epub 2011 Apr 27.
2
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况:文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
3
How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme.患者记者如何识别药物不良反应:通过英国黄卡计划报告的定性研究。
Drug Saf. 2011 May 1;34(5):429-36. doi: 10.2165/11589320-000000000-00000.
4
Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes.英国本科医学和药学课程中的药物不良反应教学。
J Clin Pharm Ther. 2004 Feb;29(1):31-5. doi: 10.1046/j.1365-2710.2003.00533.x.
5
Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.英国的药物不良反应报告:患者和医疗保健专业人员提交的黄卡报告的回顾性观察比较。
Drug Saf. 2010 Sep 1;33(9):775-88. doi: 10.2165/11536510-000000000-00000.
6
Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK.患者对在英国向黄卡计划报告药物不良反应的看法和体验。
Pharmacoepidemiol Drug Saf. 2011 May;20(5):523-31. doi: 10.1002/pds.2117. Epub 2011 Feb 17.
7
Public awareness in Wales of the UK Yellow Card scheme for reporting suspected adverse drug reactions.威尔士公众对英国药品不良反应黄卡报告计划的认知度。
Br J Clin Pharmacol. 2021 Aug;87(8):3344-3348. doi: 10.1111/bcp.14726. Epub 2021 Jan 19.
8
Making medicines safer: analysis of patient reports to the UK's Yellow Card Scheme.使药品更安全:对英国黄卡计划中患者报告的分析。
Expert Opin Drug Saf. 2019 Dec;18(12):1237-1243. doi: 10.1080/14740338.2019.1669559. Epub 2019 Sep 20.
9
Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain.英国公众对药物不良反应患者报告认知情况的调查评估。
J Clin Pharm Ther. 2012 Apr;37(2):161-5. doi: 10.1111/j.1365-2710.2011.01273.x. Epub 2011 May 18.
10
Adverse drug reaction reporting by community pharmacists-The barriers and facilitators.社区药剂师报告药物不良反应-障碍和促进因素。
Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1552-1559. doi: 10.1002/pds.4800. Epub 2019 May 27.

引用本文的文献

1
Distributed Ledger Infrastructure to Verify Adverse Event Reporting (DeLIVER): Proposal for a Proof-of-Concept Study.用于验证不良事件报告的分布式账本基础设施(DeLIVER):概念验证研究提案
JMIR Res Protoc. 2021 Jun 10;10(6):e28616. doi: 10.2196/28616.
2
A cross-sectional survey of knowledge, attitude, and willingness to engage in spontaneous reporting of adverse drug reactions by Korean consumers.一项横断面调查研究,旨在了解韩国消费者对药物不良反应自发报告的知识、态度和意愿。
BMC Public Health. 2020 Oct 8;20(1):1527. doi: 10.1186/s12889-020-09635-z.
3
Postmarket surveillance: a review on key aspects and measures on the effective functioning in the context of the United Kingdom and Canada.上市后监测:关于英国和加拿大背景下有效运作的关键方面及措施的综述
Ther Adv Drug Saf. 2019 Jul 26;10:2042098619865413. doi: 10.1177/2042098619865413. eCollection 2019.
4
Awareness and compliance with pharmacovigilance requirements amongst UK oncology healthcare professionals.英国肿瘤医疗专业人员对药物警戒要求的认知与遵守情况。
Ecancermedicalscience. 2018 Feb 8;12:809. doi: 10.3332/ecancer.2018.809. eCollection 2018.
5
Editorial.
Health Expect. 2012 Dec;15(4):337-8. doi: 10.1111/hex.12023.
6
What can we learn from parents about enhancing participation in pharmacovigilance?我们可以从父母那里学到什么来增强参与药物警戒?
Br J Clin Pharmacol. 2013 Apr;75(4):1109-17. doi: 10.1111/j.1365-2125.2012.04441.x.
7
Experiences with adverse drug reaction reporting by patients: an 11-country survey.患者药物不良反应报告经验:11 国调查。
Drug Saf. 2012 Jan 1;35(1):45-60. doi: 10.2165/11594320-000000000-00000.

本文引用的文献

1
Usability testing: a review of some methodological and technical aspects of the method.可用性测试:方法的一些方法学和技术方面的回顾。
Int J Med Inform. 2010 Apr;79(4):e18-23. doi: 10.1016/j.ijmedinf.2008.12.004. Epub 2009 Apr 2.
2
A comparison of usability methods for testing interactive health technologies: methodological aspects and empirical evidence.用于测试交互式健康技术的可用性方法比较:方法学方面与实证证据
Int J Med Inform. 2009 May;78(5):340-53. doi: 10.1016/j.ijmedinf.2008.10.002. Epub 2008 Nov 29.
3
Computerized patient education in kidney transplantation: testing the content validity and usability of the Organ Transplant Information System (OTIS).肾移植中的计算机化患者教育:测试器官移植信息系统(OTIS)的内容效度和可用性。
Patient Educ Couns. 2009 Jan;74(1):110-7. doi: 10.1016/j.pec.2008.03.027. Epub 2008 Jun 2.
4
The think aloud method: a guide to user interface design.大声思考法:用户界面设计指南。
Int J Med Inform. 2004 Nov;73(11-12):781-95. doi: 10.1016/j.ijmedinf.2004.08.003.